Literature DB >> 25298242

Thulium laser versus standard transurethral resection of the prostate for benign prostatic obstruction: a systematic review and meta-analysis.

Yiping Zhu1, Jian Zhuo, Dongliang Xu, Shujie Xia, Thomas R W Herrmann.   

Abstract

PURPOSE: To assess the efficacy and safety of thulium laser versus standard transurethral resection of the prostate (TURP) for treating patients with benign prostatic obstruction.
METHODS: A systematic search of the electronic databases, including Medline, Embase, Web of Science, and The Cochrane Library, was performed up to February 1, 2014. The pooled estimates of demographic and clinical baseline characteristics, perioperative variables, complications, and postoperative efficacy including International Prostate Symptom Score (IPSS), quality of life (QoL), maximum flow rate (Qmax), and postvoid residual (PVR) were calculated.
RESULTS: Seven trials assessing thulium laser versus standard TURP were considered suitable for meta-analysis including four randomized controlled trials (RCTs) and three non-RCTs. Compared with TURP, although thulium laser prostatectomy (TmLRP) needed a longer operative time [weighted mean difference (WMD) 8.18 min; 95 % confidence interval (CI) 1.60-14.75; P = 0.01], patients having TmLRP might benefit from significantly less serum sodium decreased (-3.73 mmol/L; 95 % CI -4.41 to -3.05; P < 0.001), shorter time of catheterization (WMD -1.29 days; 95 % CI -1.95 to -0.63; P < 0.001), shorter length of hospital stay (WMD -1.83 days; 95 % CI -3.10 to -0.57; P = 0.005), and less transfusion (odds ratio 0.09; 95 % CI 0.02-0.41; P = 0.002). During the 1, 3, and, 12 months of postoperative follow-up, the procedures did not demonstrate a significant difference in IPSS, QoL, Qmax, and PVR.
CONCLUSIONS: TmLRP had a similar efficacy to standard TURP in terms of IPSS, QoL, Qmax, and PVR, and offered several advantages over TURP in terms of blood transfusion, serum sodium decreased, catheterization time, and hospital stay, while TURP was superior in terms of operation duration. Well-designed multicentric/international RCTs with long-term follow-up are still needed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25298242     DOI: 10.1007/s00345-014-1410-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  18 in total

1.  Bringing it all together: Lancet-Cochrane collaborate on systematic reviews.

Authors:  M Clarke; R Horton
Journal:  Lancet       Date:  2001-06-02       Impact factor: 79.321

2.  High-power thulium fiber laser ablation of urinary tissues at 1.94 microm.

Authors:  Nathaniel M Fried; Keith E Murray
Journal:  J Endourol       Date:  2005 Jan-Feb       Impact factor: 2.942

3.  Two-micron (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment.

Authors:  Shu-Jie Xia
Journal:  Asian J Androl       Date:  2009-04-27       Impact factor: 3.285

4.  [5-year follow-up to transurethral vaporesection of the prostate using the 2 micron continuous wave laser for the treatment of benign prostatic hyperplasia].

Authors:  Yong Xu; Dong-chong Sun; Yong Yang; Zhi-tao Wei; Bao-fa Hong; Xu Zhang
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2013-02-01

5.  Two-micrometer thulium laser resection of the prostate-tangerine technique for patients with acute urinary retention.

Authors:  Jian Zhuo; Hai-bin Wei; Fu-jun Zhao; Feng Sun; Bang-min Han; Xiao-wen Sun; Shu-jie Xia
Journal:  Lasers Med Sci       Date:  2013-11-05       Impact factor: 3.161

6.  Comparison of 2-microm continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1-year follow-up.

Authors:  Wei J Fu; Xu Zhang; Yong Yang; Bao F Hong; Jiang P Gao; Wei Cai; Peng Zhang; Xiao X Wang
Journal:  Urology       Date:  2009-10-12       Impact factor: 2.649

Review 7.  Thulium: YAG 2 mum cw laser prostatectomy: where do we stand?

Authors:  T Bach; S J Xia; Y Yang; S Mattioli; G M Watson; A J Gross; T R W Herrmann
Journal:  World J Urol       Date:  2010-03-05       Impact factor: 4.226

8.  Is it necessary and feasible to increase the efficiency of 2-µm thulium laser resection of the prostate?

Authors:  Jian Zhuo; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2013-05-06       Impact factor: 3.285

9.  A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results.

Authors:  Di Cui; Feng Sun; Jian Zhuo; Xiaowen Sun; Bangmin Han; Fujun Zhao; Yifeng Jing; Jun Lu; Shujie Xia
Journal:  World J Urol       Date:  2013-08-03       Impact factor: 4.226

10.  Thulium laser vaporesection versus standard transurethral resection of the prostate: a randomized trial with transpulmonary thermodilution hemodynamic monitoring.

Authors:  Hao Yan; Tong-Wen Ou; Liang Chen; Qi Wang; Fei Lan; Peng Shen; Jin Li; Jian-Jun Xu
Journal:  Int J Urol       Date:  2012-10-23       Impact factor: 3.369

View more
  13 in total

1.  Thulium laser VapoResection of the prostate versus traditional transurethral resection of the prostate or transurethral plasmakinetic resection of prostate for benign prostatic obstruction: a systematic review and meta-analysis.

Authors:  Zheng Deng; Menghao Sun; Yiping Zhu; Jian Zhuo; Fujun Zhao; Shujie Xia; Bangmin Han; Thomas R W Herrmann
Journal:  World J Urol       Date:  2018-04-12       Impact factor: 4.226

2.  T. R. W. Herrmann and T. Bach (eds.): Editorial comment on "What is relevant for Lasers in Urology?".

Authors:  Jens Rassweiler
Journal:  World J Urol       Date:  2015-02-14       Impact factor: 4.226

3.  Update on lasers in urology 2015.

Authors:  Thomas R W Herrmann; Thorsten Bach
Journal:  World J Urol       Date:  2015-04       Impact factor: 4.226

4.  The efficacy and safety of 2-μm continuous laser in the treatment of high-risk patients with benign prostatic hyperplasia.

Authors:  Wei Tao; Chuanyang Sun; Boxin Xue; Dongrong Yang; Mingchao Wang; Chunjie Cai; Yuxi Shan
Journal:  Lasers Med Sci       Date:  2016-12-13       Impact factor: 3.161

5.  Transurethral laser versus open simple prostatectomy for large volume prostates: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Wei Haibin; Qian Lin; Wu Junxiu; Wang Heng; Zhang Qi; Wang Yanpeng; Zhang Dahong
Journal:  Lasers Med Sci       Date:  2020-10-12       Impact factor: 3.161

Review 6.  Epidemiology and treatment modalities for the management of benign prostatic hyperplasia.

Authors:  Soum D Lokeshwar; Benjamin T Harper; Eric Webb; Andre Jordan; Thomas A Dykes; Durwood E Neal; Martha K Terris; Zachary Klaassen
Journal:  Transl Androl Urol       Date:  2019-10

7.  [Long-term outcome after endoscopic enucleation of the prostate : From monopolar enucleation to HoLEP and from HoLEP to EEP].

Authors:  T R W Herrmann
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

8.  Comparison of the efficacy and safety of transurethral laser versus open prostatectomy for patients with large-sized benign prostatic hyperplasia: A meta-analysis of comparative trials.

Authors:  Hai-Bin Wei; Bing-Yi Guo; Yao-Fen Tu; Xuan-Han Hu; Wei Zheng; Da-Hong Zhang; Jian Zhuo
Journal:  Investig Clin Urol       Date:  2022-04-12

9.  Two-micrometer thulium laser resection of the prostate-tangerine technique in benign prostatic hyperplasia patients with previously negative transrectal prostate biopsy.

Authors:  Jian Zhuo; Hai-Bin Wei; Fei Zhang; Hai-Tao Liu; Fu-Jun Zhao; Bang-Min Han; Xiao-Wen Sun; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2017 Mar-Apr       Impact factor: 3.285

10.  Cricopharyngeal myotomy with thulium laser through flexible endoscopy: proof-of-concept study.

Authors:  Stefano Siboni; Alberto Aiolfi; Chiara Ceriani; Gian Eugenio Tontini; Luigi Bonavina
Journal:  Endosc Int Open       Date:  2018-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.